Showing results (1401-1410 of 3,900) with videos related to

Sort By:
Pageof 390
Circulation|June 15, 1999
Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathyC Heymes, M Vanderheyden, J G Bronzwaer, et al.
Circulation|November 1, 1995
Enhancement of left ventricular relaxation in the isolated heart by an angiotensin-converting enzyme inhibitorP B Anning, R M Grocott-Mason, M J Lewis, et al.
The New England Journal of Medicine|May 18, 1995
Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of lateralityS H Britz-Cunningham, M M Shah, C W Zuppan, et al.
The Journal of Biological Chemistry|October 26, 2017
MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cellsDaniel Yee, Kunal M Shah, Mark C Coles, et al.
Pharmacoepidemiology and Drug Safety|September 17, 2009
Calcium supplementation, cardiovascular disease and mortality in older womenSunil M Shah, Iain M Carey, Tess Harris, et al.
Die Pharmazie|September 6, 2008
Development and characterization of bicalutamide-poloxamer F68 solid dispersion systemsP P Sancheti, V M Vyas, M Shah, et al.
Applied and Environmental Microbiology|December 31, 2008
Poly-N-acetylglucosamine matrix polysaccharide impedes fluid convection and transport of the cationic surfactant cetylpyridinium chloride through bacterial biofilmsKrishnaraj Ganeshnarayan, Suhagi M Shah, Matthew R Libera, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2008
Functional significance of axonal Kv7 channels in hippocampal pyramidal neuronsMala M Shah, Michele Migliore, Ignacio Valencia, et al.
Parkinsonism & Related Disorders|March 7, 2008
Clinical features at first visit and rapid disease progression in Parkinson's diseaseLeslie W Ferguson, Michele L Rajput, Nazeem Muhajarine, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 18, 2017
Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine-N-oxide for the treatment of solid tumorsVidhi M Shah, Duc X Nguyen, Adel Alfatease, et al.
Pageof 390